The company was incorporated in 2011 and seeks to invest in companies that have the potential to generate substantial revenues through the development of biopharmaceutical drugs. Its Non-Executive Chairman, Jim Mellon, co-invests wherever possible in investments that he has identified. Agronomics, founded in 2011, is a venture capital firm that invests in the consumer products, consumer services, and healthcare sectors, with a focus on cellular agriculture. The company has established a portfolio of over 20 companies at the Pre-Seed to Series C stage in this sector, seeking to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage.